The Institute for Clinical and Economic Review has identified five drugs — Biktarvy, Darzalex, Entresto, Cabometyx, and ...
AZoLifeSciences on MSN2h
Exosome-Mediated Immune Escape and Tumor Growth in Hepatocellular CarcinomaThe TIME is a dynamic network composed of cancer cells, immune cells, and stromal components. During the early stages of ...
The TIME is a dynamic network composed of cancer cells, immune cells, and stromal components. During the early stages of tumorigenesis, the TIME attempts to eliminate abnormal cells through immune ...
When a room of physicians at ASH 2024 was asked whether they had prescribed a gene therapy in a commercial context, only a ...
Results from the company’s Phase I trial found its prodrug, SPT-300, was well tolerated, opening the doors to a Phase IIb trial ...
Hepion Pharmaceuticals ( (HEPA) ) just unveiled an announcement.
Hepatocellular carcinoma (HCC) stands as the dominant form of liver cancer, ranking as the fourth leading cause of cancer-related deaths globally.
Hepion Pharmaceuticals, Inc. (Nasdaq: HEPA) (the “Company” or “Hepion”), a clinical stage biopharmaceutical company that had ...
DOVER, Del. and EPALINGES, Switzerland, Dec. 11, 2024 /PRNewswire/ -- Pilatus Biosciences Inc. announced that the U.S. Food ...
The patient, diagnosed with a large hepatocellular carcinoma in the right lobe of the liver, faced significant challenges due ...
Hepatocellular carcinoma (HCC) is a significant global health issue, ranking as the sixth most prevalent malignancy and the ...
Raveesh Kunwar Malik, a 36-year-old lawyer from Zirakpur, donates his organs saving six lives after a tragic motorcycle ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback